Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Spotlight

GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines

Business

Deals
Earnings
Manufacturing

Policy & Regulation

Regulatory Landscape
Drug Pricing
IP & Litigation

Tools & Trackers

What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings

Conference Coverage

Partner Insights

Generics Bulletin Perspectives

Exploring market-shifting topics for the off-patent sector.

Medtech Insight

Generics Bulletin

Celltrion Enlists Lonza To Help Make Its Remsima

Sep 05 2019

• By David Wallace

Lonza — Lonza Will Help Celltrion Satisfy Demand For Infliximab • Source: Shutterstock

Related Content

Teva Gets Canadian Rituximab Nod, But Barriers May Remain

Apr 15 2019

Further Victory For Celltrion and Teva, As Their Trastuzumab Biosimilar, Herzuma, Receives FDA Approval

Dec 17 2018

Related Companies

Celltrion, Inc.

Lonza Group AG

Johnson & Johnson

Additional Topics

Manufacturing Deals Biosimilars BioPharmaceutical

More from Manufacturing

More from Business

Twitter feed RSS feed RSS feed

About

About UsOpens in new window
Meet the Team
AdvertiseOpens in new window
Contact Us

Account

My Account
My View
Email Preferences
Start Free TrialOpens in new window

More

Generics Top 50 Ranking
Biosimilars
Generics
Value Added Medicines

Terms and Conditions Opens in new window

Privacy PolicyOpens in new window